You are here

Investment & Business opportunities

Health and life sciences, an investment in the future 

The health and life sciences sector is in a good place right now, as we explain on the page about Catalonia on this website, as it already has an innovative ecosystem, with solid projects and global recognition. Nevertheless, biotech companies need new funding to see results from their research and license candidates to the pharmaceutical industry to manufacture drugs and for these to reach patients. Now is when the return on investment gets interesting.

Foreign investment in Catalonia rose 35% in 2014. According to consultancy firm EY, Barcelona is one of the top 10 most attractive cities in Europe for investing and the European capital with the most jobs created from foreign investment.

Apart from private funding, Catalonia will receive investment of 868.4 million euros through 2020 from the European Regional Development Fund (ERDF), including the Smart Specialisation Strategy RIS3CAT, which is 68.1% more than the amount received under the 7th Framework Programme (2007-2013).

18.07.2017

Mind the Byte, a CataloniaBio member company, has closed its second crowdequity campaign after raising €309,220 from...

#Investment
23.05.2017

Anaconda Biomed, a medical device company focused on the development of the next generation of neuro-thrombectomy systems for...

#Investment
17.05.2017

InKemia IUCT Group will launch a new €10-million fund for start-ups and spin-offs in the health and life sciences. The...

#Investment
16.05.2017

Inveready, with 150 investors and a portfolio of 80 biotech and technology companies, is launching a €40-million fund,...

#Investment
17.05.2017

Mind the Byte, a company focused on the computational drug discovery through its...

#Investment
08.05.2017

Devicare, member of CataloniaBio, especialized in innovative medical devices for home care of chronic patients under (...

#Investment
20.02.2017

Biotechnology company Cebiotex, a CataloniaBio member, has raised €1.8 million after launching its second round of...

#Investment
15.02.2017

La divisió de consultoria i finances d'IMB Grup, Mabia, ha presentat...

#Investment
14.02.2017

El grup de biotecnologia InKemia, amb seu a Mollet del Vallès (Barcelona), ha iniciat una ampliació de capital amb la...

#Investment
10.02.2017

Alta Life Sciences és un nou fons en ciències de la vida impulsat per Guy Paul Nohra, soci fundador d'Alta Partners a San...

#Investment